Scorpion Venom Provides Clues to Cause, Treatment of Pancreatitis
A common result of scorpion stings, pancreatitis is an inflammation of the pancreas. ECU microbiologist Dr. Paul Fletcher believed that scorpion venom might be used as a way to discover how pancreatitis occurs – to see which cellular processes are affected at the onset of the disease.
Fletcher pinpointed a protein production system found in the pancreas that seemed to be targeted by the venom of the Brazilian scorpion Tityus serrulatus and then contacted NC State physicist Dr. Keith Weninger, who had studied that particular protein system.
“This particular protein system has special emphasis at two places in the body – the pancreas and the nervous system,” Weninger says. “In the pancreas, it is involved in the release of proteins through the membrane of a cell.” The pancreas specializes in releasing two kinds of proteins using separate cells: digestive enzymes that go into the small intestine and insulin and its relatives that go into the bloodstream, yet this same release mechanism is important in all of our cells for many processes.
Cells move components in and out through a process called vesicle fusion. The vesicle is a tiny, bubble-like chamber inside the cell that contains the substance to be moved, stored and released – in this case, proteins like enzymes or hormones. The vesicle is moved through the cell and attaches to the exterior membrane, where the vesicle acts like an airlock in a spaceship, allowing the cell membrane to open and release the proteins without disturbing the rest of the cell’s contents. The proteins that aid in this process are known as Vesicle Associated Membrane Proteins, or VAMPs.
Weninger provided Fletcher with two different VAMP proteins found in the pancreas, VAMP2 and VAMP8. They were engineered to remove the membrane attachments so they could be more easily used for experiments outside cells and tissues. Fletcher’s team demonstrated that the scorpion venom attacked the VAMP proteins, cutting them in one place and eliminating the vesicle’s ability to transport its protein cargo out of the cell.
The results were published in the March 5 issue of the Journal of Biological Chemistry.
“We found that a particular enzyme in the scorpion’s venom removes a peptide, or small protein, that allows the vesicle to fuse with the cell membrane,” Fletcher says. “If you remove a pancreatic cell’s ability to absorb or release components, you end up with pancreatitis.”
“Viruses often exploit the same mechanism of vesicle fusion, but in reverse, in order to invade cells and replicate,” Weninger adds. “This work furthers our understanding of a basic cellular process and may lead to treatments for viruses and advances in treatments like chemotherapy, by allowing targeted drug delivery only to cancer cells.”
The Department of Physics is part of NC State University’s College of Physical and Mathematical Sciences.
Media Contact
More Information:
http://www.ncsu.eduAll latest news from the category: Life Sciences and Chemistry
Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.
Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.
Newest articles
How marine worms regenerate lost body parts
The return of cells to a stem cell-like state as the key to regeneration. Many living organisms are able to regenerate damaged or lost tissue, but why some are particularly…
Nano-scale molecular detective
New on-chip device uses exotic light rays in 2D material to detect molecules. Researchers have developed a highly sensitive detector for identifying molecules via their infrared vibrational “fingerprint”. Published in Nature…
Novel CAR T-cell therapy
… demonstrates efficacy and safety in preclinical models of HER2-positive solid tumors. The p95HER2 protein is found expressed in one third of HER2+ tumors, which represent 4% of all tumors….